Overall, our data have not only uncovered an epigenetic mechanism associated with tauopathy, but also provided experimental evidence that targeting EHMT can alleviate synaptic and cognitive deficits in a tau model of neurodegenerative disorders. This evidence concerns the gene MAPT and tauopathy.